Distressing Bleeding Symptoms in Interviews of Patients With Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorder
- 8 December 2025
- journal article
- Published by Wiley in Haemophilia
- Vol. 32 (1) , 166-173
Abstract
Introduction: Hypermobile Ehlers–Danlos Syndrome (hEDS) and hypermobility spectrum disorder (HSD) are associated with symptoms in many organ, but those related to haemostasis are not fully characterized. Aims: To determine the frequency of clinically significant excessive bleeding in this population as measured by the International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH‐BAT) and its associated health‐related quality of life (HRQoL) concerns. Methods: Thirty‐five participants were enrolled from the hEDS GENE study. We use a mixed methodology approach to explore bleeding and other symptoms and their effect on participants life and health. This included self‐administered quantitative questionnaires and semi‐structured interviews, including the ISTH‐BAT. We assessed severity of distress related to bleeding using a novel quantitative assessment score based on our participant interview responses. Results: Nearly one third of participants reported clinically significant bleeding (ISTH‐BAT mean = 4.97) yet less than 10% of those received evaluation by haematology for bleeding. Heavy menstrual bleeding (HMB) was the most common bleeding symptom. Poor HRQoL related to multiple bleeding domains was reported. More than one third of participants reported significant distress from bleeding symptoms with a mean ISTH‐BAT score of 8.25. Conclusion: Bleeding is a significant clinical concern and cause of distress in people with hypermobility correlating with the severity of bleeding, reflected by a high bleeding score. This unique assessment tool needs validation in a larger patient cohort. Increased awareness and further evaluation of this condition is needed to adequately serve this patient population.Keywords
This publication has 27 references indexed in Scilit:
- Patients withEhlers–Danlossyndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journeyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2021
- Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disordersAmerican Journal of Medical Genetics Part A, 2021
- All bleeding matters … but the details may notResearch and Practice in Thrombosis and Haemostasis, 2019
- Characterizing adolescents with heavy menstrual bleeding and generalized joint hypermobilityPediatric Blood & Cancer, 2019
- The 2017 international classification of the Ehlers–Danlos syndromesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017
- Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural historyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017
- Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/ Ehlers–Danlos syndrome, hypermobility type: The link between connective tissue and psychological distress revisedAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2015
- Gynecologic and obstetric implications of the joint hypermobility syndrome (a.k.a. Ehlers–Danlos syndrome hypermobility type) in 82 Italian patientsAmerican Journal of Medical Genetics Part A, 2012
- Ehlers–Danlos syndrome hypermobility type and the excess of affected females: Possible mechanisms and perspectivesAmerican Journal of Medical Genetics Part A, 2010
- The Fatigue Severity ScaleArchives of Neurology, 1989